Details for: PRALUENT
Company: SANOFI-AVENTIS CANADA INC
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02453819 | PRALUENT | ALIROCUMAB | 75 MG / ML | SOLUTION | SUBCUTANEOUS |
02453835 | PRALUENT | ALIROCUMAB | 150 MG / ML | SOLUTION | SUBCUTANEOUS |
Summary Reports
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.